Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.
Flash Pulmonary Edema in Multiple Sclerosis.
Averting inflammation by targeting the cytokine environment.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
A phase-specific neuroimmune model of clinical depression.
Natalizumab in clinical practice: managing the risks, enjoying the benefits.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
[Recurring neuromyelitis without optic neuritis: a case report].
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Olfactory dysfunction in multiple sclerosis.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Modulation of the Innate Immune Response by Human Neural Precursors Prevails Over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model Of Pelizaeus-Merzbacher Disease.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »